
Moderna's Covid-19 vaccine is 95% effective in preventing disease, but what's more impressive is that the company designed its vaccine in just two days in January 2020.

Genetic engineering similar to Pfizer-BioNTech and Moderna's COVID-19 vaccine could help treat heart attack patients.

Two scientists who developed the mRNA technology used to make a Covid-19 vaccine have been awarded a $3 million prize.

Scientists from the University of Oxford and AstraZeneca Plc, the creators of the Covid-19 vaccine, are using similar technology to develop a vaccine capable of treating cancer.